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Abstract A mixed methods, community-based research
study was conducted to understand how provider-level
factors contribute to the African-American and white disparity in breast cancer mortality in a lower socioeconomic
status area of North St. Louis. This study used mixed
methods including: (1) secondary analysis of Missouri
Cancer Registry data on all 885 African-American women
diagnosed with breast cancer from 2000 to 2008 while
living in the geographic area of focus; (2) qualitative
interviews with a subset of these women; (3) analysis of
data from electronic medical records of the women interviewed; and (4) focus group interviews with community
residents, patient navigators, and other health care professionals. 565 women diagnosed with breast cancer from
2000 to 2008 in the geographic area were alive at the time
of secondary data analysis; we interviewed (n = 96; 17 %)
of these women. Provider-level obstacles to completion of
prescribed treatment included fragmented navigation
(separate navigators at Federally Qualified Health Centers,
surgical oncology, and medical oncology, and no navigation services in surgical oncology). Perhaps related to the
latter, women described radiation as optional, often in the
same words as they described breast reconstruction.
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Discontinuous and fragmented patient navigation leads to
failure to associate radiation therapy with vital treatment
recommendations. Better integrated navigation that continues throughout treatment will increase treatment completion with the potential to improve outcomes in African
Americans and decrease the disparity in mortality.
Keywords Cancer  Breast cancer  Radiation therapy 
Treatment  African-American  Disparities

Introduction
Breast cancer is the second leading cause of cancer death
for American women, with an estimated 232,000 new cases
of invasive breast cancer and 39,000 deaths reported
annually [1]. Despite progress in the detection and treatment of breast cancer, racial/ethnic disparities persist.
African-American women have a 41 % greater chance of
dying from breast cancer than white women, although
white women have higher incidence of the disease [1].
These differences in mortality have been attributed to a
number of factors, including problems with accessing
treatment due to socioeconomic differences, differences in
tumor stage and grade at the time of diagnosis, and variation in tumor biology [2–10].
Breast cancer rates for African-American women in the
St. Louis area (29.4 per 100,000 city, 35.7 per 100,000
county) are higher than for the state of Missouri (24.2 per
100,000) and the United States (22.6 per 100,000) compared to all other races [11]. North St. Louis, a predominantly urban, African-American area, exhibits the lowest
life expectancy at birth and the highest cancer mortality in
the St. Louis region [12]. Local researchers are focused on
assessing and intervening to reduce these trends. Among
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significant findings is that, when compared to women
referred from private healthcare facilities, women referred
from the St. Louis Safety Net system present with larger
breast tumors and experience significant delays in referral
to a St. Louis comprehensive cancer center [13, 14].
In attempting to understand contributors to AfricanAmerican and white cancer disparities, investigators have
identified factors at multiple levels of influence, from the
biological to the societal. These include proximal factors
such as biologic/genetic pathways and individual risk factors such as diet, distal factors such as societal norms, and
the intermediate factors through which distal factors are
experienced, such as social networks and healthcare institutions [15]. All of these pathways and their interactions
contribute to breast cancer disparities in the United States.
These disparities occur at three primary points: (1) lifetime
exposures and stressors; (2) access to health care; and (3)
quality of health care received [16]. Few researchers have
investigated provider-level barriers to the completion of
breast cancer treatment among racial and ethnic minority
groups as a contributor to African-American and white
breast cancer mortality disparities to the same extent as
they have individual-level barriers. An array of providerlevel structural and systemic factors has been suggested
(location of facilities, availability of oncology specialists,
etc.), but not fully explored [17–22].
This study is guided by the hypothesis that poorly done
intra- and inter-organizational referrals for North St. Louis
women contribute to their inability to complete prescribed
breast cancer treatment and thus to the African-American
and white breast cancer mortality disparity. Nationally,
African-American women are less likely to complete
treatment for breast cancer than white women [7, 23], and
we posited that the fragmented way that services are provided and the poor connection between the safety net
system and comprehensive cancer center in the region may
contribute. We pursued our inquiry using four approaches,
as outlined below.

Methods
Sample
The primary sample was breast cancer survivors who
received their first diagnosis from 2000 to 2008, while
living in one of eight zip codes. This concentration of eight
St. Louis City zip codes was chosen based on its high rates
of late stage at diagnosis forming a North St. Louis cluster
of seven zip codes in St. Louis City, an independent entity,
and one was in St. Louis County [24]. Among those women
in the primary sample that were still alive in 2012, we
sampled 96 to participate in qualitative interviews.
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We also conducted two focus groups of the St. Louis
breast health workforce; participants included breast cancer
navigators who participate in the quarterly St. Louis
Regional Breast Cancer Workgroup and providers from the
federally qualified health center (FQHC) that is a partner in
the study and the site at which most women in the Show
Me Healthy Women Missouri (SMHW) program receive a
certain or probable diagnosis of breast cancer. Clinic providers from the FQHC and two hospitals that treat the
majority of SMHW patients were invited using letters
distributed by the partners from their organizations. The
Human Research Protections Office of the School of
Medicine approved this study.
Data collection
A mixed methods approach involving both qualitative and
quantitative data collection was used to address the study’s
research question. Due to the lack of understanding of how
provider-level factors influence inability to complete
treatment, we chose an approach that would allow us to
triangulate, or cross verify information using two or more
methods. We used four methods: (1) analysis of Missouri
Cancer Registry (MCR) data; (2) qualitative interviews
with women from the registry who were alive at the time of
the study; (3) analysis of electronic medical record data of
a subsample of those survivors; and (4) focus group
interviews with providers of services to women in the
SMHW program.
Quantitative approaches were utilized to examine MCR
data to determine who among the women diagnosed with
breast cancer while living in the target area during the
targeted years was still living and to examine their
sociodemographic characteristics and treatment patterns.
Data collected from the MCR included year of diagnosis,
zip code at diagnosis, type of insurance, tumor characteristics (stage and grade), cancer status (evidence of cancer at
last contact), and vital status (whether the women were
alive at last contact). The private insurance category
included managed care, HMO, PPO, and TRICARE, while
the public insurance category included Medicaid and
Medicare (with or without supplements) and Veterans
Affairs insurance.
Qualitative approaches included interviews with African-American breast cancer survivors from the primary
sample. Recruitment was done through invitations sent by
the MCR to all women diagnosed during that period while
living in the eight zip codes, using their updated list of
survivors. Because the vast majority of women in the
sample were of very low socioeconomic status, we chose to
recruit using the three approaches, anticipating, for example, that women with frequent moves might not receive
letters sent by the MCR. We used a multifaceted approach
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supplementing mailed letters with passing out flyers in the
eight zip codes and invitations to their patients from our
provider partners.
These 60–90 min interviews took place in women’s
homes and were designed, based on narrative theory, to
evoke narratives about each woman’s breast cancer treatment experience. They were conducted by two specially
trained female African-American interviewers using a
guide jointly prepared by the authors and breast cancer
survivors living in the same zip codes [25]. Narrative
theory holds that narrative is a basic human strategy for
coming to terms with fundamental elements of experience,
such as time and process. Kleinman [26] has shown that
illness is shaped by cultural, social, and environmental
factors that affect a person’s experience of disease. The
stories patients tell provide a means of confronting contradictions between experience and expectations based on
shared cultural models about illness and treatment [27].
Among women who participated in the semi-structured
interviews, we extracted information from the electronic
medical records (EMR) of those who received their treatment at the two primary hospital providers of treatment to
women in the study. This was done to obtain what could be
gleaned from their treatment histories from the provider
perspective, looking especially for evidence of conversations between women and providers. This allowed us to
analyze the treatment trajectories of the women interviewed and compare them to the narrative accounts they
provided. Our principle aim was to determine the extent to
which these women were included in their own care, a
major goal of the Affordable Care Act (ACA) [28]. As
such, we examined medical charts for provider:patient
discussions and treatment completed. We compared the
information women reported with that recorded in their
EMR to determine concordance. Although we were aware
of no standard for recording patient and provider conversations, we wanted to determine if evidence could be found
in the EMRs of women in our sample. Consent was
obtained in person from each participant in writing prior to
each in home interview; this also included consent to
extract EMR information.
Finally, we conducted focus groups of patient navigators
and provider staff members to gain their perspectives on
the breast cancer treatment of women in the North St.
Louis cluster. Our provider partners, members of the North
St. Louis Breast Cancer Mortality Reduction Executive
Committee who represent two hospitals affiliated with an
NCI-designated comprehensive cancer center [25], recruited the breast cancer navigators and clinic service providers
to participate in the focus groups. Oncology services at the
two hospitals share practitioners. The 60-minute focus
groups of 8–10 persons were held at a community location
and led by the senior author using an interview guide
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prepared for the study. The interview guide queried participants about how services were delivered to women,
what obstacles were perceived, and how navigators and
other providers engaged with providers at other sites when
making patient referrals.
Analysis
Examination of MCR data
Data were examined to determine the number of AfricanAmerican women diagnosed with breast cancer in
2000–2008 while living in one of the eight zip codes. We
determined the number of women alive in 2012, and also
examined the percentage treated by study partners (see
Fig. 1). Univariate statistics were used to summarize each
variable taken from the MCR with means, standard deviations, frequencies, and percentages, as appropriate. Given
the amount of unknown and missing information leading to
small cell counts when stratified, nonparametric Fisher’s
exact tests were used to determine whether there were
bivariate associations between demographic characteristics
and clinical, treatment, and outcome variables measured at
last contact and categorized as follows: age (B50, C51),
insurance type (public, private), cancer status (evidence of
tumor, no evidence of tumor), cancer grade (I, II, III, IV),

885
women diagnoised with breast cancer
Missouri Cancer Registry 2000-2008

Treated elsewhere
or untreated
270 (31%)

Treated by Partners
615 (69%)

Alive
432 (70%)

Deceased
183 (30%)

Alive
133 (49%)

Deceased

137 (51%)

Interviewed
96
(17% of those alive)

Medical Record Abstraction
85
women interviewed and treated
at comprehensive cancer center

Fig. 1 Determination of women eligible for the study and treated by
partners
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surgery recommended as first course of treatment (yes, no),
surgery performed as first course of treatment (surgery
performed, surgery not part of planned treatment, surgery
recommended but not performed), and vital status (alive,
dead).
Examination of interview data
The narrative method of qualitative research was chosen to
analyze interview data. As described by Riessman [29],
narrative research analysis interprets text from participant
stories, paying particular attention to the chronological
order of the information. Our approach was to interview
and gather the personal experiences of a set of participants
and retell their story based on narrative features such as
setting, characters, and resolutions [30]. The authors collected the treatment practices of African-American women
diagnosed with breast cancer in 2000–2008 while living in
the cluster of zip codes. Interviews began with a discussion
of the participant’s understanding of her prescribed treatment and moved through events with her treatment experience. Key points were then mapped onto a timeline to
allow comparison across participants.
Interviews were transcribed, checked for accuracy, and
used to create an analytic narrative for each participant.
Analytic narratives were aggregated according to the
treatment experiences of breast cancer patients (e.g.,
screening and diagnosis, surgery, treatment, support/barriers) and compared across participants. After interview data
were synthesized, themes were developed according to
similarities of content across participants, and these themes
were reviewed independently for completeness by the first
and senior authors. NVivo 10.0 was used to store and
analyze all qualitative data files.
Examination of EMR data
Participant data were extracted from electronic medical
record (EMR) programs used at the academic medical
system: allscripts, used by outpatient clinics, and ClinDesk,
used by inpatient clinics. The EMRs were searched for
individual characteristics (age, income at time of diagnosis), clinical characteristics (tumor histology, stage, grade,
hormone receptor status), and curative breast cancer
treatment characteristics (modalities, start dates, end dates,
explanations of treatment decisions, and/or delays) [31].
The types of EMR documents analyzed included pathology
reports, treatment consultations, physician/nurse notes,
operative summaries, and treatment summaries. When a
chart entry indicated that a provider had conversed with a
participant about treatment, treatment information was
recorded as having been discussed.
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Results
Analysis of Missouri Cancer Registry data identified a total
of 885 African-American women who were diagnosed with
breast cancer from 2000 to 2008 while residing in one of
the eight target zip codes. The mean age was 61 years
(M = 60, SD = 15) at the time of the study, and 565
(64 %) of the 885 women were living (Table 1). The
majority of women were recommended 91 % (n = 770)
and received 84 % (n = 742) surgery as a first course
treatment (Table 2). Bivariate analysis revealed that age
was significantly associated with receipt of first course
surgery (p = 0.007), cancer grade (p = 0.003), and vital
status (p \ 0.001). Insurance status was significantly
associated with vital status (p = 0.009), surgery recommended (p \ 0.001), and surgery performed (p \ 0.001) as
first course of treatment and cancer grade (p = 0.024). We
found that women who did not receive surgery as a first
course treatment tended to be older, have public insurance,
less likely to have localized tumors, and had tumors that
were larger.
Ninety-six (17 %) of the 565 eligible women alive at the
time of the study agreed to be interviewed for the study.
They had a mean age of 63 years. Half received their
suspicious or confirmed diagnosis of breast cancer through
a screening mammogram at an FQHC, St. Louis County
clinic, community clinic, or hospital. Eighty-five women
(89 %) eventually received treatment at the NCI-designated cancer center with which the two hospitals are
affiliated.
Medical record extractions were completed for all 85
participants. The EMRs were examined to determine what
treatment information or instruction was given to the
women by providers, identify the services they received,
and compare with interview data.
The 96 interviews analyzed yielded two overarching
themes: (1) fragmentation of services and (2) limited
knowledge of breast cancer treatment. First, the fragmentation of services for women led to increased delays in
treatment initiation. Half (n = 48) of the participants
reported receiving an abnormal mammogram at a community hospital or FQHC. Thirteen of those women
reported completing appointments at a second community
site before connecting to a treatment facility, adding a
delay in treatment initiation.
Second, participants said that they had difficulty processing treatment information due to nerves and the speed
with which it was presented to them. One participant
reported, ‘‘[They] wanted me to have surgery… I thought
that I should get a second opinion because I didn’t
understand why me. But I did not know how.’’ In particular, women reported problems understanding the purpose
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Table 1 Selected
characteristics of AfricanAmerican breast cancer cases
diagnosed in the in the eight
target zip codes between 2000
and 2008
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Variable (n = 885)

Frequency

Percent

Demographic characteristics
Age at diagnosis: mean (SD)

61 (15)

Age category
B 50

254

29

C 51

631

71

St. Louis County

620

70

St. Louis City County

265

30

1

0.1

County of residence at diagnosis

Type of insurancea
No insurance
Public insurance

160

18

Private insurance

78

39

Unknown/missing

646

73

Cancer stage
Localized

219

25

Regional

171

19

Distant

41

5

Unknown/missing

454

51

Grade I

128

14

Grade II

266

30

Grade III

380

43

Grade IV

2

0.2

Unknown/missing

109

12

Yes

770

87

No

79

9

Unknown

36

4

742

84

Surgery not part of planned first course treatment

79

9

Surgery was recommended but not performed

26

3

Unknown

38

4

Clinical characteristics

Cancer grade

Treatment characteristics
Surgery recommended as first course treatment

Surgery was performed as first course treatment
Surgery was performed

Outcomes
Cancer status at last contact
No evidence of tumor

614

69

Evidence of tumor

217

25

Unknown

54

6

Patient alive

565

64

Patient deceased

320

36

Vital status at last contact

a

Public insurance included: Medicaid (includes those managed through a manage care plan), Medicare
(with and without supplements), Veteran Affairs, private insurance included: managed care plans, preferred
provider organizations (PPOs), health maintenance organizations (HMOs), Tricare

of radiation therapy. When asked ‘‘Did you understand
why they wanted you to have radiation before surgery?’’
one woman replied, ‘‘They wanted to shrink it first. But I

had done some research on radiation and I found out that
was not successful even though people went through that.
People did not recover. I did not want them to experiment
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Table 2 Significant
associations between
demographic, clinical,
treatment, and outcome
variables of African-American
women diagnosed between
2000 and 2008 while residing in
the eight target zip codes

Breast Cancer Res Treat (2015) 154:5–12

Demographic/clinical variables

Clinical/treatment/outcome variables

p value*

Age (B50, C51)

Surgery performed**

p = 0.007

Age

Alive at last contact

p = 0.003

Age

Cancer grade

p \ 0.001

Insurance type (public, private)

Alive at last contact

p = 0.009

Insurance type

Surgery recommended

p \ 0.001

Insurance type

Surgery performed**

p \ 0.001

Insurance type

Cancer grade

p = 0.024

Cancer stage***

Surgery recommended

p \ 0.001

Cancer stage***

Surgery performed**

p \ 0.001

Cancer stage***

Alive at last contact

p \ 0.001

Cancer stage***

Evidence of tumor at last contact

p \ 0.001

Cancer grade

Alive at last contact

p \ 0.001

* Fisher’s exact test
** Surgery performed as first course of treatment categorized (surgery performed, surgery not part of
planned treatment, surgery recommended but not performed)
*** Cancer stage is categorized (localized, regional, distant)

on me.’’ Another participant expressed concern about the
side effects of radiation treatment, stating, ‘‘I was afraid
because I lost my grandmother to cancer that I heard many
things about cancer, negative things. I was angry and did
not want to go through the side effects of radiation. I finally
broke down when….I finally decided to do it when they
told me about the success rates of survival.’’
Review of navigator and provider focus group transcripts yielded similar themes. Focus group members
echoed the theme of service fragmentation. The system of
linking FQHC breast navigators with patients involved
telephone calls rather than on-site introductions. Navigators reported receiving women’s contact information by a
primary care physician after the women received a confirmed or probable diagnosis, yet in many cases, by the
time that they called, the contact information was no longer
valid. Navigators reported frustration in trying to deal with
women’s emotions by phone. This was particularly acute in
cases where the women were frightened at the beginning of
treatment or on the verge of dropping out. Navigators
relayed that while they communicate with one another in
quarterly St. Louis Regional Breast Cancer Workgroup
meetings, ensuring continuity of care between sites and
settings remains problematical.
In comparing EMR entries with patient narratives, we
noted a disconnection between what women described as
recommended or optional treatments and what physicians
recorded in the EMR. For example, one physician recorded, ‘‘A 48 year old lady with invasive ductal carcinoma
with DCIS of left breast, which is triple negative underwent
partial mastectomy and had radiation oncology consultation. I also [stated] that she seriously reconsider
chemotherapy as she is perimenopausal with a hormone
receptor negative tumor greater than 1 cm.’’ The patient
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reported that she declined chemotherapy and was unable to
relate the information conveyed to her in any detail.

Discussion
Fragmentation of services emerged as a major obstacle to
treatment for women living in our area of focus in North St.
Louis that emerged from both narrative interviews with
women and focus groups of providers. Having navigators
associated with individual services (surgical, medical, and
radiation oncology), and settings (the FQHC and individual
hospital clinics) presents an enormous challenge to the
continuity of care that is essential to ensuring that lower
SES women engage in and are able to complete breast
cancer treatment. While communicating regularly with one
another through quarterly meetings of navigators may help
to contribute to women completing prescribed treatment,
thus decreasing the mortality disparity, it is not enough.
Our findings suggest that tying navigators to episodes of
breast cancer rather than services is a better alternative,
very much in keeping with tenets of the ACA [28].
Additionally, radiation oncology was the service least
understood by women in the study in terms of its connection to survival. Chart review revealed that patient
navigation tapers off after surgery, with only one navigator
employed by medical oncology and none in radiation
oncology. We likewise found no evidence that interprofessional team meetings included navigators. Our findings
support previous research showing the failure to ensure
continuity of service between radiation oncology and
medical oncology and surgery may interfere with the
receipt of services [31]. In comparing the women’s stories
about treatment and that of the attending physicians as
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recorded in the patient records, we found only two instances
in which providers recorded conversations with women, and
neither indicated shared decision making. Although this may
be due to conventions of recording conversations with
patients among oncologists at this cancer center, it fits with
what investigators like Peek et al. have found about disparities in shared decision making between African and
Americans with diabetes and their providers [32]. We did
find a strong temporal tie between women’s understanding
of a treatment’s link to survival and whether a navigator was
available on the service. Women were more likely to perceive radiation therapy as optional rather than linking it to
survival than chemotherapy and surgery. Where study participants appeared hesitant to follow through on
chemotherapy, they often did so based on encouragement
from patient navigators. That opportunity was not available
for patients facing radiation therapy.
The woman’s description of treatment during the interview did not always match what was recorded in the
medical record, compounded by an almost total lack of
recording about communication with women about their
treatment. We were able to determine, however, that while
some women expressed feeling that radiation was a more
optional aspect of breast cancer treatment, according to the
medical records, approximately 60 % of the women
received radiation therapy. This observation may have been
the result of difficulty remembering treatment consultations
or treatments received, misunderstanding the difference
between radiation and chemotherapy, or could have
reflected their thoughts about treatment regardless of
whether treatment was actually initiated. This may also
suggest that because of lack of knowledge about breast
cancer treatment, many women still default to their providers to make treatment decisions. It also may stem from a
failure of providers to discuss treatment with women whom
they assume will either not be able to understand their
explanations or are less interested in their care, as suggested by the Institute of Medicine report, Unequal
Treatment: Confronting Racial and Ethnic Disparities in
Health Care [33].
The analysis of data from the Missouri Cancer Registry
allowed us to gain a broader view of breast cancer treatment patterns in African-American women who reside in
North St. Louis. Although this analysis did not directly
relate to our hypothesis, it was necessary as a first step to
characterize the data and to identify women to interview. It
therefore informed the rest of the study. Approximately
12 % of the women in this sample did not receive surgery
as a first course of treatment. Differences in demographic
and clinical characteristics may shed some light on this
observation. Statistical analysis suggests that the age and
insurance status of this subsample of women may have
contributed to their relatively higher death rates. Women
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who did not receive surgery as first course treatment were
older, more likely to have public insurance, and had larger
tumors, fewer of which were localized. It is likely the
larger tumors and more advanced tumor stages required
neoadjuvant chemotherapy to shrink the tumors before
surgery or subsequent adjuvant therapies. Due to the lack
of data on treatment beyond first course, we were unable to
assess whether women with neoadjuvant chemotherapy
received surgery at a later time or whether women received
appropriate adjuvant therapies.
These women also had lower survival rates (30 %)
compared to those with first course surgical treatment
(70 %). The reduced survival may have resulted from their
older ages; older women are more likely to die from breast
cancer [34–37]. Interestingly, mortality rates for older
women have not improved as much as those for younger
women [35]. This reduced survival may be due to
undertreatment resulting from concerns about comorbidities and treatment toxicity, or age bias on the part of the
physician [35, 38, 39]. Older women are less likely to
receive aggressive surgical treatment, systematic treatment
[35, 38, 40], or expected and concordant treatment for
breast cancer [39, 40]. Additionally, African-American
women, those with public insurance, and those living in
impoverished, urban areas are also less likely to receive
expected and concordant care [41, 42]. The majority of the
women in this sample had all of these characteristics.
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